subject: PUBCHEM.COMPOUND:187888

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEMBL.COMPOUND:CHEMBL4297747

subject_name: ENDOSTATIN

object_name: nasopharyngeal carcinoma

tested_intervention: unsure


subject: CHEMBL.COMPOUND:CHEMBL4297747


subject: UMLS:C0534628

subject_name: Endostatins


subject: UMLS:C0534628


subject: UMLS:C1705207

subject_name: Endostar

tested_intervention: yes


subject: UMLS:C1705207


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Breakthrough cancer pain


subject: CHEBI:119915

object_name: outcomes general quality of life


subject: CHEBI:119915

object_name: Perceived quality of life


subject: CHEBI:119915

object_name: Good quality of life


subject: CHEBI:3139

subject_name: bleomycin

object_name: HIV-1 infection


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:73510

subject_name: Glu-Thr


subject: PR:000010374

subject_name: UNC93-like protein MFSD11


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Compulsion


subject: UNII:4F4X42SYQ6

object_name: Psychosis nos/other


subject: UNII:4F4X42SYQ6

object_name: schizoaffective disorder


subject: UNII:4F4X42SYQ6

object_name: Transient psychotic episodes


subject: UNII:4F4X42SYQ6

object_name: delusional disorder


subject: UNII:4F4X42SYQ6

object_name: psychosis


subject: UNII:4F4X42SYQ6

object_name: schizophrenia


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: coronary atherosclerosis


subject: CHEBI:49040

object_name: arteriosclerosis disorder


subject: CHEBI:49040

object_name: atherosclerosis


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Hypercholesterolemia


subject: CHEBI:39548


subject: CHEBI:39548


subject: CHEBI:39548


subject: CHEBI:31348

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Macular Edema


subject: CHEBI:32599

object_name: Post-Operative Pain


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: esophageal squamous cell carcinoma


subject: UMLS:C4086713

object_name: Oligometastatic malignant neoplasm


subject: CHEBI:84500

subject_name: varenicline


subject: UMLS:C5203351

subject_name: Furosemide Liquid Injection

object_name: heart failure


subject: UMLS:C5203351

object_name: Heart Failure, CTCAE


subject: UMLS:C5203351

object_name: ADHF


subject: UMLS:C4048177

subject_name: furosemide injection


subject: UMLS:C4048177


subject: UMLS:C4048177


subject: CHEBI:47426

subject_name: Furosemide


subject: CHEBI:47426


subject: CHEBI:47426


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: plasma cell myeloma


subject: UMLS:C3641122


subject: CHEBI:63918

subject_name: Artesunate

object_name: Plasmodium falciparum malaria


subject: UMLS:C0700599

subject_name: pyrimethamine / sulfadoxine


subject: CHEBI:27563

subject_name: arsenic atom


subject: CHEBI:233101

subject_name: Ala-Ser


subject: CHEBI:47217

subject_name: arsane


subject: CHEBI:35828


subject: PR:000022165

subject_name: putative sulfatase AslA


subject: CHEBI:74820

subject_name: Ser-Pro


subject: CHEBI:80308

subject_name: substance P


subject: PR:000016275

subject_name: trefoil factor 2


subject: UniProtKB:Q03404

subject_name: TFF2_MOUSE Trefoil factor 2 (sprot)


subject: PR:000012825

subject_name: tissue-type plasminogen activator

object_name: stroke disorder


subject: PR:000012825

object_name: cerebrovascular disorder


subject: PR:000012825

object_name: Stroke (heart beat)


subject: PR:000012825

object_name: Stroke, CTCAE


subject: CHEBI:63716

subject_name: TENOFOVIR


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:134504


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:31536

subject_name: Emtricitabine


subject: CHEBI:53256


subject: CHEBI:60744

subject_name: poly(p-phenylene ethynylene) polymer


subject: PR:000029897


subject: CHEBI:7459

subject_name: Naloxone

object_name: Dysesthesia


subject: CHEBI:7459

object_name: Central Nervous System Sensitization


subject: CHEBI:7459

object_name: Acute Pain


subject: CHEBI:7459

object_name: pulpitis


subject: UMLS:C3493499

object_name: schizophrenia


subject: UMLS:C3493499

object_name: schizoaffective disorder


subject: UMLS:C3493499

object_name: schizophrenia 18


subject: UMLS:C3493499

object_name: CNS disorder


subject: CHEBI:109549

subject_name: Ramelteon

object_name: Chronic Insomnia


subject: UMLS:C5447494

subject_name: SHP2 Inhibitor ERAS-601

object_name: chordoma


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Alzheimer disease type 1


subject: CHEBI:9168

object_name: Alzheimer disease


subject: CHEBI:143658

object_name: Ewing sarcoma


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:27666

subject_name: Dactinomycin


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: atrial fibrillation


subject: CHEBI:68579

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:68579

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Physical trauma


subject: CHEBI:25681

object_name: Injury


subject: CHEBI:25681

object_name: Trauma


subject: CHEBI:25681

object_name: post-traumatic stress disorder


subject: UMLS:C5221264

subject_name: Acetaminophen Extended-Release

object_name: osteoarthritis


subject: UMLS:C0042210

subject_name: Vaccines

object_name: dengue disease


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: CHEBI:6931

subject_name: Midazolam

object_name: insomnia


subject: CHEBI:6931

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:6931

object_name: Insomnia, CTCAE 5.0


subject: GTOPDB:4386

subject_name: FSH

object_name: infertility


subject: UMLS:C0016424

subject_name: Follicle stimulating hormone injectable


subject: CHEBI:81569

subject_name: Follitropin


subject: UMLS:C0016774

subject_name: Human Follicle-Stimulating Hormone


subject: UNII:4O2AB118LA

subject_name: GRAZOPREVIR

object_name: chronic hepatitis C virus infection


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: neoplasm


subject: UNII:GKF8S4C432

object_name: Tumor Mass


subject: DRUGBANK:DB18830

object_name: primary ciliary dyskinesia


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: Menopause present (finding)


subject: CHEBI:127342

object_name: Menopause


subject: CHEBI:127342

object_name: Cognitive impairment


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: carotid stenosis


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:8802

subject_name: Remifentanil


subject: UNII:7V6HE3DM5A

subject_name: Ocriplasmin

object_name: stroke disorder


subject: UNII:7V6HE3DM5A

object_name: cerebrovascular disorder


subject: UNII:7V6HE3DM5A

object_name: Stroke (heart beat)


subject: UNII:7V6HE3DM5A

object_name: Stroke, CTCAE


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: neuromyelitis optica


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:201491

subject_name: Amoxicillin Clavulanate

object_name: Febrile Neutropenia


subject: UMLS:C0054066

subject_name: amoxicillin / clavulanate


subject: PUBCHEM.COMPOUND:46874763


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C5139959

object_name: insomnia


subject: UNII:LMQ24G57E9

subject_name: Daridorexant


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: head and neck squamous cell carcinoma


subject: CHEBI:141969

object_name: H-ras gene mutation


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: PUBCHEM.COMPOUND:148193


subject: UMLS:C1710381

subject_name: Circadin

object_name: Postural instability


subject: CHEBI:16796

subject_name: Melatonin


subject: UMLS:C0592140

subject_name: Stilnoct


subject: CHEBI:10125

subject_name: Zolpidem


subject: CHEBI:70839

subject_name: Dasatinib

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:190514


subject: CHEBI:49375


subject: UNII:1W5N8SZD9A

subject_name: Glufosfamide

object_name: Pancreatic adenocarcinoma metastatic


subject: UMLS:C5418040

object_name: HER2 positive breast carcinoma


subject: UNII:F85N2YHE4E

subject_name: Omega-3-carboxylic acids

object_name: cardiovascular disorder


subject: UNII:F85N2YHE4E

object_name: hypertriglyceridemia


subject: UNII:F85N2YHE4E

object_name: Hypertriglyceridemia, CTCAE


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: chronic kidney disease


subject: CHEBI:168396

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: PUBCHEM.COMPOUND:188025

object_name: attention deficit hyperactivity disorder, inattentive type


subject: PUBCHEM.COMPOUND:188025


subject: CHEBI:228596

subject_name: MPH


subject: CHEBI:228596


subject: PR:000002069


subject: PR:000002069


subject: CHEBI:32090

subject_name: Rebamipide

object_name: gastritis


subject: CHEBI:32090

object_name: Gastritis, CTCAE


subject: PUBCHEM.COMPOUND:2269

object_name: HIV infection


subject: PUBCHEM.COMPOUND:2269

object_name: Mycobacterium avium complex disease


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: PUBCHEM.COMPOUND:2367

subject_name: Betnesol

object_name: Twin pregnancy, antepartum condition or complication


subject: CHEBI:3077

subject_name: Betamethasone


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone

object_name: kidney failure


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: Hypercholesterolemia


subject: UNII:V5Y646AW8S

object_name: chorea


subject: UNII:V5Y646AW8S

object_name: Huntington disease


subject: CHEBI:2618

subject_name: Amantadine


subject: CHEBI:2618


subject: CHEBI:6538

subject_name: Loratadine


subject: CHEBI:6538


subject: CHEBI:135207

subject_name: Clofedanol

object_name: Type 2 diabetes mellitus with established diabetic nephropathy


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:87631

subject_name: statin

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: CHEBI:9150

subject_name: Simvastatin


subject: MESH:C530986

subject_name: Glucerna

object_name: Diabetic


subject: MESH:C530986

object_name: abdominal obesity-metabolic syndrome


subject: MESH:C530986

object_name: metabolic syndrome X


subject: MESH:C530986

object_name: hyperglycemia


subject: MESH:C530986

object_name: Hyperglycemia, CTCAE


subject: MESH:C530986

object_name: Glucose in blood specimen above reference range


subject: UMLS:C0723575

subject_name: T-Diet


subject: UMLS:C0723575


subject: UMLS:C0723575


subject: UMLS:C0723575


subject: UMLS:C0723575


subject: UMLS:C0723575


subject: CHEBI:4974

subject_name: Famciclovir

object_name: genital herpes


subject: CHEBI:490877

subject_name: Didanosine

object_name: tuberculosis


subject: CHEBI:63577

subject_name: Lamivudine


subject: CHEBI:93775

subject_name: Amethopterin

object_name: Inflammation


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:27470

subject_name: Folic acid


subject: UMLS:C2985186

object_name: interstitial lung disease 1


subject: UMLS:C2985186

object_name: interstitial lung disease 2


subject: CHEBI:132922

object_name: acute myocarditis


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: UNII:8375F9S90C

subject_name: Pamiparib

object_name: hereditary leiomyomatosis and renal cell cancer


subject: UNII:8375F9S90C

object_name: Multiple cutaneous leiomyomas


subject: UNII:8375F9S90C

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UNII:8375F9S90C

object_name: papillary renal cell carcinoma


subject: UNII:8375F9S90C

object_name: Metastatic Renal Cell Carcinoma


subject: UNII:8375F9S90C

object_name: Metastatic Renal Cell Cancer


subject: UNII:8375F9S90C

object_name: hereditary papillary renal cell carcinoma


subject: UNII:8375F9S90C

object_name: tubulocystic renal cell carcinoma


subject: UNII:8375F9S90C

object_name: Unresectable Renal Cell Carcinoma


subject: UNII:8375F9S90C

object_name: Metastatic Renal Cell Carcinoma, Not Otherwise Specified


subject: UNII:8375F9S90C

object_name: clear cell papillary renal cell carcinoma


subject: UNII:8375F9S90C

object_name: collecting duct carcinoma


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: UMLS:C1508746

subject_name: egg extract

object_name: kwashiorkor


subject: DRUGBANK:DB10529

subject_name: Egg


subject: PUBCHEM.COMPOUND:5339

subject_name: Sulfasalazine

object_name: glioblastoma


subject: PUBCHEM.COMPOUND:5339

object_name: Childhood Glioblastoma


subject: PUBCHEM.COMPOUND:5339

object_name: adult glioblastoma


subject: PUBCHEM.COMPOUND:5339

object_name: Recurrent Childhood Glioblastoma


subject: PUBCHEM.COMPOUND:5339

object_name: Recurrent Glioblastoma


subject: PUBCHEM.COMPOUND:5339

object_name: glioma


subject: PUBCHEM.COMPOUND:5339

object_name: malignant glioma


subject: CHEBI:233413

subject_name: Denifanstat


subject: CHEBI:233413

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab

object_name: diffuse large B-cell lymphoma


subject: UNII:2Y3T5IF01Z

object_name: follicular lymphoma


subject: UNII:2Y3T5IF01Z

object_name: B-cell neoplasm


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: UMLS:C4763426

subject_name: Tuparstobart


subject: UMLS:C4763426


subject: UMLS:C4763426


subject: UMLS:C5206703

subject_name: INCAGN 02390


subject: UMLS:C5206703


subject: UMLS:C5206703


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: stroke disorder


subject: CHEBI:5118

object_name: cerebrovascular disorder


subject: CHEBI:5118

object_name: Stroke (heart beat)


subject: CHEBI:5118

object_name: Stroke, CTCAE


subject: CHEBI:5118

object_name: Motor function (finding)


subject: PUBCHEM.COMPOUND:72728820

subject_name: Moxidectin

object_name: onchocerciasis


subject: PUBCHEM.COMPOUND:53397745

subject_name: Milbemycin A4


subject: PUBCHEM.COMPOUND:57369871

subject_name: Milbemycin D


subject: UMLS:C0252664

subject_name: AIT 082

object_name: Memory Disorders


subject: CHEBI:70839

subject_name: Dasatinib

object_name: leukemia


subject: CHEBI:70839

object_name: childhood leukemia


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: metastatic colorectal cancer


subject: UNII:8F63U28T2V

subject_name: Imexon


subject: UNII:8F63U28T2V

object_name: Burkitt lymphoma


subject: UNII:8F63U28T2V

object_name: marginal zone lymphoma


subject: UNII:8F63U28T2V

object_name: MALT lymphoma


subject: UNII:8F63U28T2V

object_name: mantle cell lymphoma


subject: UNII:8F63U28T2V

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:8F63U28T2V

object_name: lymphoplasmacytic lymphoma


subject: UNII:8F63U28T2V

object_name: Waldenstrom macroglobulinemia


subject: UNII:8F63U28T2V

object_name: diffuse large B-cell lymphoma


subject: CHEBI:15544

subject_name: Alprostadil

object_name: Rest limb pain


subject: CHEBI:68573

subject_name: indacaterol maleate

object_name: chronic obstructive pulmonary disease


subject: CHEBI:91400

subject_name: Afatinib

object_name: head and neck squamous cell carcinoma


subject: GTOPDB:9592

subject_name: tislelizumab


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: UMLS:C5446895

subject_name: Anti-CTLA-4 Monoclonal Antibody IBI310

object_name: liver carcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: mucosal melanoma


subject: UNII:DPT0O3T46P

object_name: acral lentiginous melanoma


subject: UNII:DPT0O3T46P

object_name: Acral Melanoma


subject: UNII:6T4O391P5Y

subject_name: Vactosertib


subject: UNII:6T4O391P5Y


subject: UNII:6T4O391P5Y


subject: GTOPDB:13796

subject_name: serplulimab


subject: CHEMBL.COMPOUND:CHEMBL4594550

subject_name: SERPLULIMAB


subject: UMLS:C4745029

subject_name: HLX 10


subject: CHEBI:15361

subject_name: pyruvate

object_name: progressive supranuclear palsy


subject: MESH:D011773

subject_name: Pyruvates


subject: CHEBI:32816

subject_name: Pyruvic acid


subject: CHEBI:16919

subject_name: Creatine


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:231369

subject_name: Savolitinib

object_name: Advanced Gastric Adenocarcinoma


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib

object_name: adult lymphoma


subject: UNII:AG9MHG098Z

object_name: lymphoma


subject: UNII:AG9MHG098Z

object_name: pediatric lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4297207

subject_name: STANNSOPORFIN

object_name: G6PD deficiency


subject: CHEMBL.COMPOUND:CHEMBL4297207

object_name: hereditary hyperbilirubinemia


subject: CHEMBL.COMPOUND:CHEMBL4297207

object_name: hyperbilirubinemia


subject: CHEMBL.COMPOUND:CHEMBL4297207

object_name: fetal erythroblastosis


subject: UMLS:C5203017

subject_name: G-Series Nerve Agent GB

object_name: hyperglycemia


subject: UMLS:C5203017

object_name: Overweight and obesity


subject: UNII:T12B44A1OE

subject_name: Acoramidis

object_name: Cardiac amyloidosis


subject: UNII:T12B44A1OE

object_name: amyloidosis, hereditary systemic 1


subject: UNII:T12B44A1OE

object_name: familial amyloid neuropathy


subject: UNII:T12B44A1OE

object_name: ATTR Amyloidosis


subject: UNII:T12B44A1OE

object_name: cardiomyopathy


subject: UNII:T12B44A1OE

object_name: amyloidosis


subject: UNII:T12B44A1OE

object_name: heart disorder


subject: CHEBI:31687

subject_name: Idebenone

object_name: Friedreich ataxia


subject: CHEBI:31687

object_name: Friedreich ataxia 1


subject: UNII:6315412YVF

subject_name: Delafloxacin

object_name: staphylococcal infection


subject: UNII:6315412YVF

object_name: Staphylococcal Skin Infections


subject: UNII:6315412YVF

object_name: skin disease caused by bacterial infection


subject: UNII:6315412YVF

object_name: cellulitis


subject: CHEBI:6149

subject_name: Levobupivacaine

object_name: hip fracture


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: coronary atherosclerosis


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: Indolent Non-Hodgkin Lymphoma


subject: CHEBI:91397

object_name: Indolent Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:122173807

subject_name: anidulafungin

object_name: Infection


subject: PUBCHEM.COMPOUND:122173807

object_name: infectious disease


subject: PUBCHEM.COMPOUND:122173807

object_name: Adverse Event Associated with Infection


subject: PUBCHEM.COMPOUND:122173807

object_name: leukopenia


subject: PUBCHEM.COMPOUND:122173807

object_name: neutropenia


subject: PUBCHEM.COMPOUND:122173807

object_name: unspecified childhood solid tumor, protocol specific


subject: UMLS:C0532508


subject: UMLS:C0532508


subject: UMLS:C0532508


subject: UMLS:C0532508


subject: UMLS:C0532508


subject: UMLS:C0532508


subject: PUBCHEM.COMPOUND:71080313

subject_name: Volasertib

object_name: leukemia


subject: PUBCHEM.COMPOUND:71080313

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:71080313

object_name: neoplasm


subject: UNII:6EM57086EA


subject: UNII:6EM57086EA


subject: UNII:6EM57086EA


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: Candidiasis of lung


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEMBL.COMPOUND:CHEMBL3545346

object_name: Reflux


subject: CHEMBL.COMPOUND:CHEMBL3545346

object_name: Heartburn


subject: CHEBI:145371

subject_name: Binimetinib

object_name: skin melanoma


subject: CHEBI:145371

object_name: skin carcinoma


subject: CHEBI:145371

object_name: skin neoplasm


subject: CHEBI:145371

object_name: skin cancer


subject: UNII:8L7891MRB6

subject_name: Encorafenib


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: CHEBI:114785

subject_name: Erlotinib

object_name: cholangiocarcinoma


subject: CHEBI:114785

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: CHEBI:114785

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: CHEBI:114785

object_name: gallbladder cancer


subject: CHEBI:114785

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: CHEBI:114785

object_name: Stage III Gallbladder Cancer AJCC v8


subject: CHEBI:114785

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: CHEBI:114785

object_name: gallbladder carcinoma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: DRUGBANK:DB08937

object_name: metastatic colorectal cancer


subject: CHEBI:90876

subject_name: Lonsurf


subject: PUBCHEM.COMPOUND:135839365

subject_name: Lobucavir

object_name: cytomegalovirus infection


subject: PUBCHEM.COMPOUND:135839365

object_name: HIV infection


subject: CHEBI:5931

subject_name: insulin human

object_name: type 1 diabetes mellitus 1


subject: CHEBI:74705

subject_name: Met-Leu

object_name: rhinitis


subject: CHEBI:74705

object_name: Rhinoconjunctivitis


subject: CHEBI:74705

object_name: Seasonal asthma


subject: CHEBI:74705

object_name: Allergy


subject: CHEBI:74705

object_name: History of allergies


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: UNII:HD4TW8S2VK

subject_name: Pridopidine

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UNII:HD4TW8S2VK

object_name: amyotrophic lateral sclerosis


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: end stage renal failure


subject: PUBCHEM.COMPOUND:73005958

object_name: Chronic uremia


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: CHEBI:38940

subject_name: Sunitinib

object_name: lung cancer


subject: CHEBI:38940

object_name: lung neoplasm


subject: CHEBI:38940

object_name: lung carcinoma


subject: CHEBI:135948

subject_name: Amifampridine

object_name: Paresis


subject: CHEBI:135948

object_name: Muscle weakness


subject: UMLS:C5235868

object_name: Advanced Hepatocellular Carcinoma


subject: UMLS:C4745029

subject_name: HLX 10


subject: CHEBI:85994

subject_name: Lenvatinib


subject: UNII:3I8JKL1CHB

object_name: cancer


subject: UNII:3I8JKL1CHB

object_name: neoplasm


subject: UNII:3I8JKL1CHB

object_name: Gastrointestinal Intraepithelial Neoplasia of Mouse


subject: UMLS:C3641173

subject_name: PROMITIL


subject: UMLS:C3641173


subject: UMLS:C3641173


subject: UNII:T4RS462G19

subject_name: Almonertinib

object_name: non-small cell lung carcinoma


subject: CHEBI:74705

object_name: open-angle glaucoma


subject: PR:000009425


subject: PR:000016318


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: chronic leukemia


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: outcomes general quality of life


subject: CHEBI:41879

object_name: Perceived quality of life


subject: CHEBI:41879

object_name: Good quality of life


subject: CHEBI:41879

object_name: pelvic organ prolapse


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: pancreatitis


subject: PUBCHEM.COMPOUND:11306691

object_name: Pancreatitis, CTCAE 5.0


subject: PUBCHEM.COMPOUND:11306691

object_name: Pancreatitis, CTCAE 3.0


subject: PUBCHEM.COMPOUND:11306691

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:11306691

object_name: Diabetes


subject: PUBCHEM.COMPOUND:11306691

object_name: diabetes mellitus


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:40237


subject: CHEBI:40237


subject: CHEBI:40237


subject: CHEBI:40237


subject: CHEBI:40237


subject: UMLS:C4287697

object_name: cervical cancer


subject: UMLS:C4287697

object_name: cervical carcinoma


subject: UMLS:C4287697

object_name: Advanced cancer


subject: UMLS:C5447533

subject_name: Fluorine F 18 3F-PHPG

object_name: autonomic nervous system disorder


subject: UMLS:C3711128


subject: CHEBI:135569

subject_name: Arotinolol

object_name: Nocturnal hypertension


subject: CHEBI:2668

subject_name: Amlodipine


subject: CHEBI:3757

subject_name: Clonidine


subject: UMLS:C2830223


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Nasopharyngeal cancer recurrent


subject: CHEBI:175901

subject_name: Gemcitabine


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:64312

subject_name: Memantine

object_name: pervasive developmental disorder


subject: CHEBI:64312

object_name: autism


subject: CHEBI:85974

subject_name: edoxaban tosylate hydrate

object_name: atrial fibrillation


subject: CHEBI:85974

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:85974

object_name: Atrial Fibrillation, CTCAE


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: PUBCHEM.COMPOUND:11635624


subject: PUBCHEM.COMPOUND:11635624


subject: UNII:8D81JS19ET

subject_name: ferroquine

object_name: malaria


subject: GTOPDB:9972


subject: UMLS:C4548943


subject: CHEBI:31547

subject_name: Eplerenone

object_name: myocardial ischemia


subject: CHEBI:31547

object_name: Family history of ischemic heart disease


subject: CHEBI:24866

subject_name: salt

object_name: heart failure


subject: CHEBI:24866

object_name: Heart Failure, CTCAE


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Advanced breast cancer


subject: CHEBI:5801

object_name: Carcinoma breast stage IV


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Acquired trigger finger


subject: CHEBI:74705

object_name: trigger thumb


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: UMLS:C0281722

subject_name: gp100 Antigen

object_name: melanoma


subject: DRUGBANK:DB17475

subject_name: Incomplete Freund's adjuvant


subject: MESH:C477385

subject_name: montanide ISA 51


subject: CHEBI:177298

object_name: Homologous Recombination Deficiency


subject: CHEBI:177298

object_name: triple-negative breast carcinoma


subject: CHEBI:177298

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:240107

subject_name: Bromfenac

object_name: atopic conjunctivitis


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: colon carcinoma


subject: CHEBI:175901

object_name: colorectal cancer


subject: CHEBI:175901

object_name: colon cancer


subject: CHEBI:175901

object_name: rectal carcinoma


subject: CHEBI:175901

object_name: rectal cancer


subject: CHEBI:175901

object_name: Childhood Rectal Carcinoma


subject: CHEBI:175901

object_name: Childhood Breast Carcinoma


subject: CHEBI:175901

object_name: breast carcinoma


subject: CHEBI:175901

object_name: breast cancer


subject: CHEBI:175901

object_name: ovarian cancer


subject: CHEBI:175901

object_name: ovarian neoplasm


subject: CHEBI:175901

object_name: ovarian carcinoma


subject: CHEBI:175901

object_name: colorectal carcinoma


subject: CHEBI:175901

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:175901

object_name: endometrial cancer


subject: CHEBI:175901

object_name: uterine corpus cancer


subject: CHEBI:175901

object_name: endometrial carcinoma


subject: CHEBI:175901

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:175901

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:175901

object_name: sarcoma


subject: CHEBI:175901

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:175901

object_name: soft tissue sarcoma


subject: UMLS:C4733491

subject_name: Chk1 Inhibitor LY2880070

object_name: Solid Neoplasm


subject: UMLS:C4733491

object_name: pancreatic neoplasm


subject: UMLS:C4733491

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4733491

object_name: malignant pancreatic neoplasm


subject: UMLS:C4733491

object_name: colon carcinoma


subject: UMLS:C4733491

object_name: colorectal cancer


subject: UMLS:C4733491

object_name: colon cancer


subject: UMLS:C4733491

object_name: rectal carcinoma


subject: UMLS:C4733491

object_name: rectal cancer


subject: UMLS:C4733491

object_name: Childhood Rectal Carcinoma


subject: UMLS:C4733491

object_name: Childhood Breast Carcinoma


subject: UMLS:C4733491

object_name: breast carcinoma


subject: UMLS:C4733491

object_name: breast cancer


subject: UMLS:C4733491

object_name: ovarian cancer


subject: UMLS:C4733491

object_name: ovarian neoplasm


subject: UMLS:C4733491

object_name: ovarian carcinoma


subject: UMLS:C4733491

object_name: colorectal carcinoma


subject: UMLS:C4733491

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4733491

object_name: endometrial cancer


subject: UMLS:C4733491

object_name: uterine corpus cancer


subject: UMLS:C4733491

object_name: endometrial carcinoma


subject: UMLS:C4733491

object_name: triple-negative breast carcinoma


subject: UMLS:C4733491

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C4733491

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C4733491

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C4733491

object_name: sarcoma


subject: UMLS:C4733491

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C4733491

object_name: soft tissue sarcoma


subject: UMLS:C4733491

object_name: neoplasm


subject: CHEBI:231683

subject_name: Anakinra

object_name: end stage renal failure


subject: CHEBI:231683

object_name: Chronic uremia


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Deviated nasal septum


subject: CHEBI:64356

subject_name: Pregabalin


subject: UMLS:C1165603

subject_name: Dextrose solution

object_name: osteoarthritis, knee


subject: UMLS:C1165603

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C1165603

object_name: obesity


subject: UMLS:C1165603

object_name: Obesity, CTCAE


subject: CHEBI:17234

subject_name: D-glucose


subject: CHEBI:63624

subject_name: Telbivudine

object_name: chronic hepatitis B virus infection


subject: CHEBI:63624

object_name: hepatitis B


subject: CHEBI:135342

subject_name: Reboxetine

object_name: obstructive sleep apnea syndrome


subject: UMLS:C2726511

subject_name: Wilate

object_name: hereditary von Willebrand disease


subject: UMLS:C2726511

object_name: von Willebrand disease (hereditary or acquired)


subject: PUBCHEM.COMPOUND:2269

object_name: cystic fibrosis


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: pancreatitis


subject: CHEBI:28787

object_name: Pancreatitis, CTCAE 5.0


subject: CHEBI:28787

object_name: Pancreatitis, CTCAE 3.0


subject: CHEBI:63634

subject_name: Valdecoxib


subject: CHEBI:63634


subject: CHEBI:63634


subject: CHEBI:28072

object_name: intrahepatic cholangiocarcinoma


subject: CHEBI:70744

subject_name: Gly-Pro


subject: UniProtKB:P08668

subject_name: GP_HANTV Envelopment polyprotein (sprot)


subject: UniProtKB:P27312

subject_name: GP_PUUMS Envelopment polyprotein (sprot)


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: MESH:D003287

subject_name: Contrast Media

object_name: Blood Clot


subject: MESH:D003287

object_name: thrombosis


subject: MESH:D003287

object_name: Thrombosis of blood vessel


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Burkitt's lymphoma refractory


subject: CHEBI:63791

object_name: Non-Hodgkin's lymphoma transformed recurrent


subject: CHEBI:63791

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEBI:63791

object_name: Follicular lymphoma refractory


subject: CHEBI:63791

object_name: B-cell lymphoma, unspecified


subject: CHEBI:63791

object_name: Diffuse large B-cell lymphoma recurrent


subject: CHEBI:63791

object_name: Recurrent Burkitt Lymphoma


subject: CHEBI:63791

object_name: Recurrent Childhood Burkitt Lymphoma


subject: CHEBI:63791

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:63791

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:63791

object_name: Follicular lymphoma recurrent


subject: CHEBI:63791

object_name: Lymphoma, Mixed-Cell, Follicular


subject: CHEBI:63791

object_name: Lymphoma, Small Cleaved-Cell, Follicular


subject: CHEBI:63791

object_name: grade 3A follicular lymphoma


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: UMLS:C4329321

object_name: head and neck squamous cell carcinoma


subject: UNII:J27WDC343N

subject_name: MESOTHELIN

object_name: Mesothelioma


subject: UNII:J27WDC343N

object_name: mesothelial neoplasm


subject: UNII:J27WDC343N

object_name: malignant mesothelioma


subject: PUBCHEM.COMPOUND:3084049

subject_name: hyaluronan


subject: PUBCHEM.COMPOUND:3084049


subject: PUBCHEM.COMPOUND:3084049


subject: CHEBI:150712

subject_name: Hyaluronic acid


subject: CHEBI:150712


subject: CHEBI:150712


subject: CHEBI:132153

subject_name: hyaluronate


subject: CHEBI:132153


subject: CHEBI:132153


subject: GTOPDB:6753

subject_name: osteopontin


subject: GTOPDB:6753


subject: GTOPDB:6753


subject: UNII:FNE8GU45NU


subject: UNII:FNE8GU45NU


subject: UNII:FNE8GU45NU


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: myalgic encephalomeyelitis/chronic fatigue syndrome


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:77733

subject_name: Verapamil

object_name: cardiomyopathy


subject: CHEBI:77733

object_name: systolic heart failure


subject: CHEBI:77733

object_name: myocardial disorder


subject: CHEBI:73501

subject_name: Glu-Phe-Val

object_name: HIV infection


subject: CHEBI:173106

subject_name: ferroptocide


subject: UniProtKB:P36394

subject_name: SRY_RAT Sex-determining region Y protein (sprot)


subject: PR:000015643

subject_name: sex-determining region Y protein


subject: UNII:841L03HG64

subject_name: Pentavalent Antimony

object_name: cutaneous leishmaniasis


subject: UNII:841L03HG64

object_name: leishmaniasis


subject: CHEBI:15365

subject_name: Aspirin

object_name: preeclampsia


subject: CHEBI:499361

subject_name: Aprepitant

object_name: heroin dependence


subject: CHEBI:499361

object_name: opiate dependence


subject: CHEBI:499361

object_name: substance-related disorder


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: leukemia


subject: UNII:PVI5M0M1GW

object_name: childhood leukemia


subject: UNII:PVI5M0M1GW

object_name: adult lymphoma


subject: UNII:PVI5M0M1GW

object_name: lymphoma


subject: UNII:PVI5M0M1GW

object_name: pediatric lymphoma


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PUBCHEM.COMPOUND:5458171

subject_name: MITOXANTRONE HYDROCHLORIDE


subject: PUBCHEM.COMPOUND:5458171


subject: PUBCHEM.COMPOUND:5458171


subject: PUBCHEM.COMPOUND:5458171


subject: PUBCHEM.COMPOUND:5458171


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:50729


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: PUBCHEM.COMPOUND:4739

subject_name: Vidarbine


subject: PUBCHEM.COMPOUND:4739


subject: PUBCHEM.COMPOUND:4739


subject: PUBCHEM.COMPOUND:4739


subject: PUBCHEM.COMPOUND:4739


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:27834

subject_name: Pentostatin


subject: CHEBI:27834


subject: CHEBI:27834


subject: CHEBI:27834


subject: CHEBI:27834


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PUBCHEM.COMPOUND:137319706

subject_name: Orforglipron

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:137319706

object_name: obesity


subject: PUBCHEM.COMPOUND:137319706

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:137319706

object_name: Overweight


subject: PUBCHEM.COMPOUND:137319706

object_name: Overweight or obesity


subject: UNII:7ZW40D021M

subject_name: ORFORGLIPRON


subject: UNII:7ZW40D021M


subject: UNII:7ZW40D021M


subject: UNII:7ZW40D021M


subject: UNII:7ZW40D021M


subject: PUBCHEM.COMPOUND:175542

subject_name: Docosahexaenoicacid(DHA)

object_name: hypertriglyceridemia


subject: PUBCHEM.COMPOUND:175542

object_name: Hypertriglyceridemia, CTCAE


subject: CHEBI:36005

subject_name: docosahexaenoic acid


subject: CHEBI:36005


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:16016


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: DRUGBANK:DB17556

object_name: acute myeloid leukemia by FAB classification


subject: DRUGBANK:DB17556

object_name: acute myeloid leukemia


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: Vasodilation disorder


subject: CHEBI:28787

object_name: Oral soft tissue conditions


subject: CHEBI:240107

subject_name: Bromfenac

object_name: cataract


subject: CHEBI:240107

object_name: Cataract, CTCAE 3.0


subject: CHEBI:240107

object_name: Cataract, CTCAE 5.0


subject: CHEBI:240107

object_name: cataract on exam (physical finding)


subject: CHEBI:240107

object_name: Inflammation


subject: UMLS:C4721945

subject_name: perflutren, human albumin microspheres

object_name: Locally Advanced Breast Carcinoma


subject: UMLS:C4721945

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Rotator Cuff Tendinitis


subject: CHEBI:8707

subject_name: Quetiapine

object_name: generalized anxiety disorder


subject: CHEBI:8707

object_name: major depressive disorder


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: leukemia


subject: PUBCHEM.COMPOUND:596

object_name: childhood leukemia


subject: CHEBI:94265

subject_name: Cerubidin


subject: CHEBI:94265


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:41977


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:31822

subject_name: MERCAPTOPURINE


subject: CHEBI:31822


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:2208


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: UNII:7D96IR0PPM


subject: UNII:FTK8U1GZNX

subject_name: THIOGUANINE


subject: UNII:FTK8U1GZNX


subject: CHEBI:9555

subject_name: Tioguanine


subject: CHEBI:9555


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:23965

subject_name: estradiol

object_name: multiple sclerosis


subject: PUBCHEM.COMPOUND:13505135

subject_name: Nomegestrol acetate


subject: CHEBI:26195

subject_name: polyphenol

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:26195

object_name: obesity


subject: CHEBI:26195

object_name: Obesity, CTCAE


subject: CHEBI:26195

object_name: type 2 diabetes mellitus


subject: CHEBI:26195

object_name: Diabetes


subject: CHEBI:26195

object_name: diabetes mellitus


subject: GTOPDB:7983

subject_name: lintuzumab

object_name: acute myeloid leukemia by FAB classification


subject: GTOPDB:7983

object_name: acute myeloid leukemia


subject: GTOPDB:7983

object_name: Adult Myelodysplastic Syndrome


subject: GTOPDB:7983

object_name: childhood myelodysplastic syndrome


subject: GTOPDB:7983

object_name: Myelodysplastic Syndrome, CTCAE


subject: GTOPDB:7983

object_name: myeloproliferative neoplasm


subject: GTOPDB:7983

object_name: juvenile myelomonocytic leukemia


subject: GTOPDB:7983

object_name: chronic myelomonocytic leukemia


subject: CHEMBL.COMPOUND:CHEMBL2109150

subject_name: LINTUZUMAB


subject: CHEMBL.COMPOUND:CHEMBL2109150


subject: CHEMBL.COMPOUND:CHEMBL2109150


subject: CHEMBL.COMPOUND:CHEMBL2109150


subject: CHEMBL.COMPOUND:CHEMBL2109150


subject: CHEMBL.COMPOUND:CHEMBL2109150


subject: CHEMBL.COMPOUND:CHEMBL2109150


subject: CHEMBL.COMPOUND:CHEMBL2109150


subject: UMLS:C0530093


subject: UMLS:C0530093


subject: UMLS:C0530093


subject: UMLS:C0530093


subject: UMLS:C0530093


subject: UMLS:C0530093


subject: UMLS:C0530093


subject: UMLS:C0530093


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Severe Acute Malnutrition


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:6532

subject_name: Loperamide

object_name: diarrhea


subject: CHEBI:6532

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:6532

object_name: Diarrhea, CTCAE


subject: CHEBI:31498

subject_name: Simethicone


subject: CHEBI:31498


subject: CHEBI:31498


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: chronic pain (diagnosis)


subject: PUBCHEM.COMPOUND:4715169

object_name: Chronic pain


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356


subject: UMLS:C4764258

subject_name: Linvoseltamab

object_name: plasma cell myeloma


subject: UMLS:C4086017

subject_name: BTK Inhibitor

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C4086017

object_name: chronic leukemia


subject: DRUGBANK:DB17258

object_name: Adult Gliosarcoma


subject: DRUGBANK:DB17258

object_name: gliosarcoma


subject: DRUGBANK:DB17258

object_name: Childhood Gliosarcoma


subject: DRUGBANK:DB17258

object_name: Grade III Childhood Astrocytoma


subject: DRUGBANK:DB17258

object_name: Adult Anaplastic Astrocytoma


subject: DRUGBANK:DB17258

object_name: anaplastic astrocytoma


subject: DRUGBANK:DB17258

object_name: glioblastoma


subject: DRUGBANK:DB17258

object_name: Brain Stem Glioblastoma


subject: DRUGBANK:DB17258

object_name: glioma susceptibility 1


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UMLS:C3489972

object_name: atrial fibrillation


subject: UMLS:C3489972

object_name: Atrial Fibrillation by ECG Finding


subject: UMLS:C3489972

object_name: Atrial Fibrillation, CTCAE


subject: UMLS:C3541386

subject_name: Estrogens, endocrine therapy drugs

object_name: endometriosis


subject: UMLS:C3537250

subject_name: ESTROGENS, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM


subject: CHEBI:50114

subject_name: estrogen


subject: UMLS:C3714615

subject_name: Estrogens Drug Class


subject: CHEBI:9150

subject_name: Simvastatin


subject: MESH:C000721066

object_name: Drug Interactions


subject: CHEBI:31413

subject_name: Clobazam

object_name: pervasive developmental disorder


subject: CHEBI:31413

object_name: autism


subject: CHEBI:31413

object_name: autism spectrum disorder


subject: UNII:P826WR56FI

object_name: type 2 diabetes mellitus


subject: UMLS:C4281781

subject_name: Bacillus subtilis antigen

object_name: Parkinson disease


subject: DRUGBANK:DB11347

subject_name: Bacillus subtilis


subject: CHEBI:232328

subject_name: Dordaviprone

object_name: H3 K27M Variant


subject: CHEBI:232328

object_name: glioma


subject: CHEBI:232328

object_name: malignant glioma


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: hypochondroplasia


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C2825029

subject_name: Recombinant Human Growth Hormone [EPC]


subject: UMLS:C0059291

subject_name: endotoxin, Escherichia coli

object_name: Inflammation


subject: HMDB:HMDB0013470

subject_name: LPS with O-antigen


subject: CHEBI:16412

subject_name: Lysophosphotidylserine


subject: PUBCHEM.COMPOUND:155977629


subject: CHEBI:89981

subject_name: Endotoxins


subject: CHEBI:52603


subject: GTOPDB:5019

subject_name: LPS


subject: CHEMBL.COMPOUND:CHEMBL4630622


subject: PR:000001155

subject_name: Toll-like receptor 4


subject: PUBCHEM.COMPOUND:9848354

subject_name: Qsymia

object_name: Adolescent Obesity


subject: CHEBI:8080

subject_name: Phentermine


subject: UMLS:C5237346

subject_name: STING Agonist IMSA101

object_name: Adult Solid Neoplasm


subject: MESH:D000082082

subject_name: Immune Checkpoint Inhibitors


subject: CHEBI:151

subject_name: ISOCITRIC ACID


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: hypertension


subject: CHEBI:89324

object_name: Hypertension, CTCAE


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL


subject: UNII:1C6V77QF41


subject: UNII:55KHL3P693

subject_name: Galcanezumab

object_name: migraine


subject: UNII:55KHL3P693

object_name: migraine with or without aura, susceptibility to, 1


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Hodgkin Disease


subject: UNII:DPT0O3T46P

object_name: Adult Classical Hodgkin Lymphoma


subject: UMLS:C1873773

subject_name: Ice Pharmaceutical


subject: UMLS:C1873773


subject: MESH:D007053

subject_name: Ice


subject: MESH:D007053


subject: CHEBI:6809

subject_name: Metamfetamine


subject: CHEBI:6809


subject: PR:000005366

subject_name: cocaine esterase


subject: PR:000005366


subject: PR:000002309


subject: PR:000002309


subject: CHEBI:16108

subject_name: Dihydroxyacetone phosphate


subject: CHEBI:16108


subject: CHEBI:31355

subject_name: Carboplatin

object_name: non-small cell squamous lung carcinoma


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: CHEBI:233402

subject_name: zipalertinib


subject: UNII:T4YMU8TW9H

subject_name: ZIPALERTINIB


subject: CHEBI:10125

subject_name: Zolpidem

object_name: delirium


subject: CHEBI:10125

object_name: Delirium, CTCAE


subject: CHEBI:10125

object_name: Pelvis fracture


subject: CHEBI:10125

object_name: Hip Fracture, CTCAE


subject: CHEBI:10125

object_name: hip fracture


subject: CHEBI:35469

subject_name: antidepressant

object_name: endogenous depression


subject: CHEBI:35469

object_name: major depressive disorder


subject: UMLS:C0003289

subject_name: Antidepressive Agents


subject: UMLS:C0003289


subject: CHEBI:4911

subject_name: Etoposide

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:4911

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:4911

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:94686

subject_name: Orlistat

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:94686

object_name: obesity


subject: CHEBI:94686

object_name: Obesity, CTCAE


subject: CHEBI:94686

object_name: Overweight


subject: UMLS:C5854509

subject_name: ADC 9MW2821

object_name: cervical cancer


subject: UMLS:C5854509

object_name: cervical carcinoma


subject: PUBCHEM.COMPOUND:262961

object_name: Tourette syndrome


subject: PUBCHEM.COMPOUND:262961

object_name: Tourette syndrome in adolescence


subject: CHEBI:11909

subject_name: Sepranolone


subject: CHEBI:11909


subject: CHEBI:61049

subject_name: Tacrolimus

object_name: Facial edema


subject: CHEBI:61049

object_name: Edema Face, CTCAE


subject: CHEBI:145372

subject_name: Gilteritinib

object_name: adult acute myeloid leukemia


subject: CHEBI:145372

object_name: childhood acute myeloid leukemia


subject: CHEBI:145372

object_name: acute myeloid leukemia


subject: UMLS:C2947577

subject_name: Dioscorea villosa tuber extract

object_name: Androgen excess


subject: UMLS:C2947577

object_name: Oligomenorrhea


subject: UMLS:C2947577

object_name: amenorrhea


subject: UMLS:C2947577

object_name: Amenorrhea, CTCAE


subject: CHEBI:24848

subject_name: inositol


subject: CHEBI:24848


subject: CHEBI:24848


subject: CHEBI:24848


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: periodontitis, aggressive 1


subject: CHEBI:3732

object_name: acute pericementitis


subject: UMLS:C0114882

subject_name: doxorubicin-HPMA conjugate

object_name: Childhood Breast Carcinoma


subject: UMLS:C0114882

object_name: breast carcinoma


subject: UMLS:C0114882

object_name: breast cancer


subject: PUBCHEM.COMPOUND:173480

object_name: Parkinson disease


subject: PUBCHEM.COMPOUND:173480

object_name: Dyskinesia, Medication-Induced


subject: PUBCHEM.COMPOUND:173480

object_name: L-dopa causing adverse effects in therapeutic use


subject: UMLS:C3896652


subject: UMLS:C3896652


subject: UMLS:C3896652


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: acne


subject: CHEBI:45783

subject_name: Imatinib

object_name: sickle cell disease


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: colorectal cancer


subject: CHEBI:63791

object_name: colorectal carcinoma


subject: CHEBI:63791

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:60787

subject_name: TIMOLOL

object_name: glaucoma


subject: CHEBI:60787

object_name: Glaucoma, CTCAE


subject: CHEBI:39465

subject_name: timolol


subject: CHEBI:39465


subject: UMLS:C3661049

object_name: Dyskinesia


subject: UMLS:C3661049


subject: UMLS:C3661049

object_name: Parkinsonism


subject: UMLS:C3661049

object_name: movement disorder


subject: CHEBI:7476

subject_name: Naproxen

object_name: pelvic pain on the left


subject: CHEBI:7476

object_name: pelvic pain occurs with urination


subject: CHEBI:7476

object_name: pelvic pain occurs with bowel movement


subject: CHEBI:7476

object_name: pelvic pain decreasing in severity


subject: CHEBI:7476

object_name: Pelvic pain female


subject: CHEBI:7476

object_name: pelvic pain increasing in severity


subject: CHEBI:7476

object_name: male pelvic pain


subject: CHEBI:7476

object_name: pelvic pain to the rear


subject: CHEBI:7476

object_name: pelvic pain on the right


subject: CHEBI:7476

object_name: pelvic pain decreasing in frequency


subject: CHEBI:7476

object_name: Pelvic pain


subject: CHEBI:7476

object_name: Pelvic Pain, CTCAE 5.0


subject: CHEBI:7476

object_name: pelvic pain causes awakening at night


subject: CHEBI:7476

object_name: pelvic pain increasing in frequency


subject: CHEBI:7476

object_name: pelvic pain occurs with intercourse


subject: CHEBI:7476

object_name: pelvic pain in front


subject: CHEBI:7476

object_name: Chronic pelvic pain of female


subject: CHEBI:7476

object_name: Dysmenorrhea, CTCAE


subject: CHEBI:7476

object_name: Dysmenorrhea


subject: UMLS:C2974205

object_name: chronic obstructive pulmonary disease


subject: CHEBI:90962

subject_name: Utibron Neohaler


subject: CHEBI:50249

subject_name: anticoagulant

object_name: atrial fibrillation


subject: CHEBI:50249

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:50249

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:50249

object_name: Adverse effects in the therapeutic use of anticoagulants


subject: CHEBI:50249

object_name: Frail elderly syndrome


subject: UMLS:C0003280

subject_name: Anticoagulants


subject: UMLS:C0003280


subject: UMLS:C0003280


subject: UMLS:C0003280


subject: UMLS:C0003280


subject: CHEBI:67201

subject_name: synthetic cannabinoid

object_name: major affective disorder 4


subject: CHEBI:67201

object_name: major affective disorder 7


subject: CHEBI:67201

object_name: bipolar disorder


subject: CHEBI:67201

object_name: major affective disorder 6


subject: CHEBI:67201

object_name: major affective disorder 2


subject: CHEBI:67201

object_name: major affective disorder 8


subject: CHEBI:67201

object_name: major affective disorder 9


subject: CHEBI:67201

object_name: major affective disorder 1


subject: CHEBI:67201

object_name: major affective disorder 5


subject: CHEBI:63637

subject_name: Vemurafenib

object_name: thyroid tumor


subject: CHEBI:63637

object_name: thyroid gland carcinoma


subject: CHEBI:63637

object_name: thyroid cancer


subject: CHEBI:135962

subject_name: Dapoxetine

object_name: impotence


subject: CHEBI:135962

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:135962

object_name: Erectile dysfunction


subject: CHEBI:135962

object_name: premature ejaculation


subject: PUBCHEM.COMPOUND:6093437


subject: PUBCHEM.COMPOUND:6093437


subject: PUBCHEM.COMPOUND:6093437


subject: PUBCHEM.COMPOUND:6093437


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: prostate cancer


subject: CHEBI:233362

object_name: prostate neoplasm


subject: CHEBI:233362

object_name: Neoplasm Metastasis


subject: CHEBI:233362

object_name: Neoplasm of the genitourinary tract


subject: DRUGBANK:DB14235

subject_name: Bilberry

object_name: myocardial infarction


subject: DRUGBANK:DB14235

object_name: Myocardial Infarction, CTCAE


subject: DRUGBANK:DB14235

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:49668

subject_name: Gefitinib

object_name: skin squamous cell carcinoma


subject: CHEBI:49668

object_name: Recurrent Skin Carcinoma


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: No-Reflow Phenomenon


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: Apathy


subject: CHEBI:6887

object_name: On examination - apathetic


subject: CHEBI:6887

object_name: Parkinson disease


subject: CHEBI:229212

subject_name: Pirtobrutinib

object_name: thrombocytopenia due to immune destruction


subject: CHEBI:231683

subject_name: Anakinra

object_name: cortisol; hypersecretion


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: UMLS:C0282575

subject_name: Micronutrients

object_name: heart failure


subject: UMLS:C0282575

object_name: congestive heart failure


subject: UMLS:C0282575

object_name: ischemic cardiomyopathy


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348


subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: diffuse midline glioma, H3 K27M-mutant


subject: GTOPDB:7988

object_name: diffuse intrinsic pontine glioma


subject: UNII:6NS400BXKH


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: UMLS:C1570308


subject: CHEBI:23080

subject_name: cerotoyl group


subject: CHEBI:23080


subject: PR:000015192

subject_name: sodium- and chloride-dependent creatine transporter 1


subject: PR:000015192


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: UMLS:C5237721

subject_name: FAK1 Inhibitor IN10018

object_name: Recurrent ovarian cancer


subject: UMLS:C3530062

object_name: sickle cell disease


subject: CHEBI:567361

subject_name: Cladribine

object_name: hairy cell leukemia


subject: CHEBI:567361

object_name: refractory hairy cell leukemia


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: CHEBI:44423

subject_name: Hydroxyurea


subject: CHEBI:44423

object_name: malaria


subject: CHEBI:45783

subject_name: Imatinib

object_name: leukemia


subject: CHEBI:45783

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: Chuvash polycythemia


subject: PUBCHEM.COMPOUND:3062

object_name: Chuvash erythrocytosis


subject: PUBCHEM.COMPOUND:3062

object_name: VHL Gene Mutation


subject: PUBCHEM.COMPOUND:3062

object_name: familial polycythemia


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:4551


subject: CHEBI:4551


subject: CHEBI:4551


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: Neck Carcinoma


subject: UNII:6A901E312A

object_name: head and neck neoplasm


subject: UNII:6A901E312A

object_name: head and neck cancer


subject: UNII:6A901E312A

object_name: cancer


subject: UNII:6A901E312A

object_name: neoplasm


subject: UNII:6A901E312A

object_name: squamous cell carcinoma


subject: UNII:6A901E312A

object_name: carcinoma


subject: UNII:6A901E312A

object_name: Disseminated Malignant Neoplasm


subject: UNII:6A901E312A

object_name: Embolism, Tumor


subject: UNII:6A901E312A

object_name: Neoplasm Metastasis


subject: UNII:6A901E312A

object_name: Metastatic Lesion


subject: CHEBI:31355

subject_name: Carboplatin


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab


subject: UMLS:C4287697


subject: CHEBI:66964

subject_name: Dronabinol

object_name: obstructive sleep apnea syndrome


subject: UMLS:C4733650

subject_name: Prodrug APX001

object_name: candidemia


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: Cushing syndrome


subject: CHEBI:70746

object_name: adrenal gland hyperfunction


subject: CHEBI:70746

object_name: hyperaldosteronism


subject: CHEBI:70746


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:70752


subject: UNII:2158753C7E

subject_name: Relacorilant


subject: UNII:2158753C7E


subject: UNII:2158753C7E


subject: UNII:2158753C7E


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: ovarian cancer


subject: UNII:5S371K6132

object_name: ovarian neoplasm


subject: UNII:5S371K6132

object_name: ovarian carcinoma


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Post-Operative Pain


subject: UMLS:C0445115

subject_name: Normal saline


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: colon carcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: colon cancer


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Postoperative cognitive dysfunction


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UMLS:C0770246

subject_name: PROTEIN SUPPLEMENTS

object_name: Physical trauma


subject: UMLS:C0770246

object_name: Injury


subject: UMLS:C0770246

object_name: Trauma


subject: UMLS:C0770246

object_name: Critical Illness


subject: UMLS:C0770246

object_name: malnutrition


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: coronary artery disorder


subject: CHEBI:8228

object_name: coronary atherosclerosis


subject: CHEBI:8228

object_name: Angina pectoris


subject: UMLS:C4083270

subject_name: BIBW 2992

object_name: esophageal squamous cell carcinoma


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Squamous cell carcinoma of head and neck metastatic


subject: CHEBI:72317

object_name: head and neck squamous cell carcinoma


subject: CHEBI:72317

object_name: Squamous cell carcinoma of head and neck recurrent


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UNII:PQX0D8J21J


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C4053607

object_name: triple-negative breast carcinoma


subject: UMLS:C4053607

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C4053607

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: UMLS:C4053607

object_name: melanoma


subject: GTOPDB:7989

subject_name: sirukumab

object_name: asthma


subject: CHEMBL.COMPOUND:CHEMBL1743071

subject_name: SIRUKUMAB


subject: UMLS:C3254570


subject: CHEBI:38940

subject_name: Sunitinib

object_name: non-small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109330

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEMBL.COMPOUND:CHEMBL2109330

object_name: amyotrophic lateral sclerosis


subject: CHEMBL.COMPOUND:CHEMBL2109330

object_name: motor neuron disorder


subject: UMLS:C5417932

subject_name: IC 14


subject: UMLS:C5417932


subject: UMLS:C5417932


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: autoimmune pulmonary alveolar proteinosis


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UNII:3DGD69C6PV

subject_name: brigatinib

object_name: Solid Neoplasm


subject: UNII:3DGD69C6PV

object_name: Anaplastic lymphoma kinase positive anaplastic large cell lymphoma


subject: CHEBI:6121

subject_name: Ketamine

object_name: Acute Pain


subject: CHEBI:31547

subject_name: Eplerenone

object_name: heart failure


subject: UNII:71492GE1FX

subject_name: Benralizumab

object_name: atopic eczema


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: rectal carcinoma


subject: UNII:M487QF2F4V

object_name: rectal cancer


subject: UNII:M487QF2F4V

object_name: Childhood Rectal Carcinoma


subject: UMLS:C1321603

subject_name: INJECTION, AMIFOSTINE, 500 MG ADMINISTERED


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:34373

subject_name: Gaboxadol

object_name: Primary Insomnia


subject: UMLS:C1170024

subject_name: Adderall-XR

object_name: cocaine dependence


subject: CHEBI:63631

subject_name: Topiramate


subject: CHEBI:261649

subject_name: Bismuth subsalicylate

object_name: diarrhea


subject: CHEBI:261649

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:261649

object_name: Diarrhea, CTCAE


subject: CHEBI:177833

subject_name: Cilengitide

object_name: Adult Acute Myeloid Leukemia in Remission


subject: CHEBI:177833

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:177833

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:177833

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:177833

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:177833

object_name: adult acute monocytic leukemia


subject: CHEBI:177833

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:177833

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:177833

object_name: Adult Acute Basophilic Leukemia


subject: CHEBI:177833

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:177833

object_name: Adult Erythroleukemia


subject: CHEBI:177833

object_name: Adult Acute Eosinophilic Leukemia


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: CHEBI:135954

subject_name: Bilastine

object_name: Atopic rhinitis


subject: CHEBI:135954

object_name: Hay fever


subject: UMLS:C2752138

subject_name: aloe vera homeopathic preparation

object_name: Xerostomia


subject: DRUGBANK:DB13906

subject_name: Aloe vera leaf


subject: UMLS:C0995182

subject_name: Aloe vera preparation


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: cannabis abuse


subject: UMLS:C0183753

subject_name: Swab specimen

object_name: Neonatal infection


subject: CHEBI:16302

object_name: arteriosclerosis disorder


subject: CHEBI:16302

object_name: atherosclerosis


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UNII:81G40H8B0T


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: UMLS:C3714656


subject: CHEBI:12777

subject_name: Vitamin A


subject: CHEBI:12777


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: UMLS:C2825076


subject: GTOPDB:12990

subject_name: sintilimab

object_name: salivary gland cancer


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: CHEBI:31355

subject_name: Carboplatin


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:6413

subject_name: Letrozole

object_name: hereditary breast ovarian cancer syndrome


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: type 1 diabetes mellitus


subject: UMLS:C1099192


subject: UMLS:C1706991

subject_name: Bowman-Birk Inhibitor Concentrate

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:21K6M2I7AG

subject_name: interferon gamma-1b

object_name: Mycosis fungoides/Sezary syndrome refractory


subject: UNII:21K6M2I7AG

object_name: Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:21K6M2I7AG

object_name: Mycosis fungoides/Sezary syndrome stage II


subject: UNII:21K6M2I7AG

object_name: Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:21K6M2I7AG

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: UNII:21K6M2I7AG

object_name: Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:21K6M2I7AG

object_name: Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:21K6M2I7AG

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:21K6M2I7AG

object_name: Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:21K6M2I7AG

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: UNII:21K6M2I7AG

object_name: Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:21K6M2I7AG

object_name: Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:21K6M2I7AG

object_name: Metastatic synovial sarcoma


subject: UNII:21K6M2I7AG

object_name: Unresectable Synovial Sarcoma


subject: UNII:21K6M2I7AG

object_name: Metastatic Round Cell Liposarcoma


subject: UNII:21K6M2I7AG

object_name: Myxoid liposarcoma metastatic


subject: UMLS:C0021741

subject_name: Actimmune


subject: UMLS:C0021741


subject: UMLS:C0021741


subject: UMLS:C0021741


subject: UMLS:C0021741


subject: UMLS:C0021741


subject: UMLS:C0021741


subject: UMLS:C0021741


subject: UMLS:C0021741


subject: UMLS:C0021741


subject: UMLS:C0021741


subject: UMLS:C0021741


subject: UMLS:C0021741


subject: UMLS:C0021741


subject: UMLS:C0021741


subject: UMLS:C0021741


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: no feeling or sensation of skin


subject: CHEBI:60789

object_name: Sensory Loss


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:3215


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: autoimmune thrombocytopenia


subject: UNII:4F4X42SYQ6

object_name: autoimmune thrombocytopenic purpura


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Childhood Breast Carcinoma


subject: CHEBI:231614

object_name: breast carcinoma


subject: CHEBI:231614

object_name: breast cancer


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:E3B2GI648A

subject_name: Belatacept

object_name: Lung transplant rejection


subject: UNII:E3B2GI648A

object_name: Antibody-mediated rejection


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib


subject: PUBCHEM.COMPOUND:73005958


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: PUBCHEM.COMPOUND:91976568

subject_name: Teduglutide

object_name: short bowel syndrome


subject: UMLS:C1098514


subject: CHEBI:45716

subject_name: Vorinostat

object_name: malignant pleural mesothelioma


subject: CHEMBL.COMPOUND:CHEMBL1237024

subject_name: SIPULEUCEL-T

object_name: metastatic prostate carcinoma


subject: UMLS:C5555055

subject_name: CDK9 Inhibitor KB-0742

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C5555055

object_name: non-Hodgkin lymphoma


subject: UMLS:C5555055

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C5555055

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:188074

object_name: Alzheimer disease


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:95067

subject_name: Iniparib

object_name: triple-negative breast carcinoma


subject: CHEBI:95067

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C1831868

subject_name: BSI 201


subject: UMLS:C1831868


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: ovarian cancer


subject: UNII:2S9ZZM9Q9V

object_name: ovarian neoplasm


subject: UMLS:C1452745

object_name: type 2 diabetes mellitus


subject: UMLS:C1452745

object_name: Diabetes


subject: UMLS:C1452745

object_name: diabetes mellitus


subject: CHEBI:135515

subject_name: Bendamustine

object_name: acute leukemia


subject: CHEBI:135515

object_name: Hodgkin Disease


subject: CHEBI:135515

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:135515

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:681569

subject_name: Clofarabine


subject: CHEBI:681569


subject: CHEBI:681569


subject: CHEBI:681569


subject: CHEBI:681569


subject: CHEBI:681569


subject: CHEBI:681569


subject: CHEBI:681569


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PR:000017019

subject_name: UBX domain-containing protein 11


subject: PR:000017019

object_name: pneumonia


subject: PR:000017019

object_name: COVID-19-Associated Pneumonia


subject: UMLS:C5435306


subject: UMLS:C5435306


subject: UMLS:C5435306


subject: UMLS:C1330419

subject_name: Niacin ER


subject: CHEBI:135942

subject_name: Laropiprant


subject: PUBCHEM.COMPOUND:10216733

subject_name: DIASTEREOMER 2


subject: UMLS:C5703063

subject_name: Plasma, high titer covid-19 convalescent, each unit


subject: UMLS:C5703063

object_name: severe acute respiratory syndrome


subject: UMLS:C5703063

object_name: Coronavinae infectious disease


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Advanced breast cancer


subject: CHEBI:31348

object_name: HER2 positive breast carcinoma


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib


subject: PUBCHEM.COMPOUND:78384800

subject_name: Taxanes


subject: PUBCHEM.COMPOUND:78384800


subject: UMLS:C0796419


subject: UMLS:C0796419


subject: UMLS:C3541958

subject_name: Taxanes, antineoplastic


subject: UMLS:C3541958


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: CHEBI:93235

subject_name: flupentixol

object_name: substance-related disorder


subject: CHEBI:5121

subject_name: flupenthixol


subject: CHEBI:7852

subject_name: Oxycodone

object_name: Withdrawal Symptoms


subject: UMLS:C5856416

subject_name: DPPG2-based Thermosensitive Liposomes Encapsulating Doxorubicin DPPG2-TSL-DOX

object_name: sarcoma


subject: UMLS:C5856416

object_name: soft tissue sarcoma


subject: CHEBI:50223

subject_name: Dexrazoxane


subject: CHEBI:50223


subject: CHEBI:3347

subject_name: Candesartan

object_name: essential hypertension, genetic


subject: CHEBI:3347

object_name: essential hypertension


subject: UMLS:C0590658

subject_name: Adalat


subject: UMLS:C0590658


subject: CHEBI:7565

subject_name: Nifedipine


subject: CHEBI:7565


subject: UMLS:C0700869


subject: UMLS:C0700869


subject: CHEBI:64073

object_name: type 2 diabetes mellitus


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: UMLS:C0021658

subject_name: Humulin N


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative


subject: UNII:4FR53SIF3A

object_name: adult acute lymphoblastic leukemia


subject: CHEBI:229221

subject_name: Fruquintinib

object_name: Advanced Pancreatic Carcinoma


subject: CHEBI:109549

subject_name: Ramelteon

object_name: insomnia


subject: CHEBI:109549

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:109549

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:23359

subject_name: colchicine

object_name: heart failure


subject: CHEBI:23359

object_name: Heart Failure, CTCAE


subject: CHEBI:41060

subject_name: IBANDRONATE

object_name: postmenopausal osteoporosis


subject: UNII:UMD7G2653W

subject_name: Ibandronate


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Mesothelioma


subject: CHEBI:31355

object_name: mesothelial neoplasm


subject: CHEBI:31355

object_name: malignant mesothelioma


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:95021


subject: UNII:63WI9S8P1M

subject_name: Tinlarebant

object_name: Stargardt disease


subject: CHEBI:15365

subject_name: Aspirin

object_name: heart disorder


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:25681

object_name: obesity


subject: CHEBI:25681

object_name: Obesity, CTCAE


subject: CHEBI:25681

object_name: Inflammation


subject: CHEBI:25681

object_name: type 2 diabetes mellitus


subject: CHEBI:25681

object_name: Insulin resistance


subject: CHEBI:25681

object_name: Dyslipidemia


subject: CHEBI:60799

subject_name: Esketamine

object_name: liver carcinoma


subject: UMLS:C1569021

subject_name: INGAP peptide

object_name: type 1 diabetes mellitus 1


subject: UMLS:C1569021

object_name: type 1 diabetes mellitus


subject: UNII:FU77B4U5Z0

subject_name: Ustekinumab


subject: UNII:FU77B4U5Z0


subject: MESH:C000627770

subject_name: folfirinox

object_name: digestive system neuroendocrine tumor, grade 1/2


subject: MESH:C000627770

object_name: digestive system neuroendocrine neoplasm


subject: MESH:C000627770

object_name: pancreatic neoplasm


subject: MESH:C000627770

object_name: exocrine pancreatic carcinoma


subject: MESH:C000627770

object_name: malignant pancreatic neoplasm


subject: MESH:C000627770

object_name: pancreatic endocrine carcinoma


subject: GTOPDB:4934

subject_name: G-CSF


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000008699

subject_name: homeobox protein Hox-B2

object_name: Geographic atrophy


subject: PR:000008699

object_name: age-related macular degeneration


subject: PR:000009418


subject: PR:000009418


subject: PR:000009495

subject_name: keratin, type II cytoskeletal 8


subject: PR:000009495


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:28X28X9OKV

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: UNII:28X28X9OKV

object_name: Oropharyngeal squamous cell carcinoma stage II


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)

object_name: infertility


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: CHEBI:63581

subject_name: Stavudine

object_name: HIV infection


subject: CHEBI:119915

subject_name: Fentanyl

object_name: tetralogy of fallot


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEMBL.COMPOUND:CHEMBL1743006

subject_name: DALOTUZUMAB

object_name: Solid Neoplasm


subject: UMLS:C2987605

subject_name: dalotuzumab


subject: CHEBI:82677

subject_name: ridaforolimus


subject: PUBCHEM.COMPOUND:58827053

subject_name: Osilodrostat

object_name: Cushing syndrome


subject: PUBCHEM.COMPOUND:58827053

object_name: hyperaldosteronism


subject: PUBCHEM.COMPOUND:58827053

object_name: ectopic ACTH secretion syndrome


subject: PUBCHEM.COMPOUND:58827053

object_name: adrenal carcinoma


subject: PUBCHEM.COMPOUND:58827053

object_name: adrenal cortex carcinoma


subject: PUBCHEM.COMPOUND:58827053

object_name: adrenal adenoma


subject: PUBCHEM.COMPOUND:58827053

object_name: primary pigmented nodular adrenocortical disease


subject: PUBCHEM.COMPOUND:58827053

object_name: Cushing syndrome due to macronodular adrenal hyperplasia


subject: PUBCHEM.COMPOUND:58827053

object_name: ACTH-independent macronodular adrenal hyperplasia 1


subject: PUBCHEM.COMPOUND:134129863

subject_name: VELDOREOTIDE

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:134129863

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:134129863

object_name: breast cancer


subject: PUBCHEM.COMPOUND:134129863

object_name: skin disorder


subject: PUBCHEM.COMPOUND:134129863

object_name: skin neoplasm


subject: PUBCHEM.COMPOUND:134129863

object_name: skin cancer


subject: CHEBI:74947

subject_name: Thalidomide

object_name: Gastrointestinal vascular malformation


subject: CHEBI:75551


subject: CHEBI:82297

subject_name: carbon black

object_name: IgE responsiveness, atopic


subject: PUBCHEM.COMPOUND:172866199

subject_name: Carbon Black


subject: CHEBI:27594

subject_name: Graphite


subject: UNII:MLC36A7X39

subject_name: sodium tetrametaphosphate

object_name: adult lymphoma


subject: UNII:MLC36A7X39

object_name: lymphoma


subject: UNII:MLC36A7X39

object_name: pediatric lymphoma


subject: UNII:MLC36A7X39

object_name: leukemia


subject: UNII:MLC36A7X39

object_name: childhood leukemia


subject: UNII:MLC36A7X39

object_name: Hodgkin Disease


subject: UNII:MLC36A7X39

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UNII:MLC36A7X39

object_name: Myelodysplasia


subject: UNII:MLC36A7X39

object_name: Adult Myelodysplastic Syndrome


subject: UNII:MLC36A7X39

object_name: childhood myelodysplastic syndrome


subject: UNII:MLC36A7X39

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:MLC36A7X39

object_name: plasma cell myeloma


subject: UMLS:C1161438

subject_name: Cyclophos brand of cyclophosphamide


subject: UMLS:C1161438


subject: UMLS:C1161438


subject: UMLS:C1161438


subject: UMLS:C1161438


subject: UMLS:C1161438


subject: UMLS:C1161438


subject: UMLS:C1161438


subject: UMLS:C1161438


subject: UMLS:C1161438


subject: UMLS:C1161438


subject: UMLS:C1161438


subject: UNII:3A189DH42V

subject_name: Alemtuzumab


subject: UNII:3A189DH42V


subject: UNII:3A189DH42V


subject: UNII:3A189DH42V


subject: UNII:3A189DH42V


subject: UNII:3A189DH42V


subject: UNII:3A189DH42V


subject: UNII:3A189DH42V


subject: UNII:3A189DH42V


subject: UNII:3A189DH42V


subject: UMLS:C0935720

subject_name: TriAb

object_name: lung cancer


subject: UMLS:C0935720

object_name: lung neoplasm


subject: UMLS:C0935720

object_name: lung carcinoma


subject: UMLS:C1328690

subject_name: Monoclonal Antibody GD2 Anti-Idiotype Vaccine


subject: UMLS:C1328690


subject: UMLS:C1328690


subject: UMLS:C0002525

subject_name: Amino Acids, Essential

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C0002525

object_name: obesity


subject: UMLS:C0002525

object_name: Obesity, CTCAE


subject: UMLS:C0002525

object_name: Heart Disease Risk Factors


subject: HMDB:HMDB0001349

subject_name: Selenium

object_name: colorectal cancer


subject: HMDB:HMDB0001349

object_name: colorectal carcinoma


subject: HMDB:HMDB0001349

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: HMDB:HMDB0001349

object_name: precancerous condition


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: UMLS:C0521939


subject: UMLS:C0521939


subject: UMLS:C0521939


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: UMLS:C3714803


subject: UMLS:C3714803


subject: UMLS:C3714803


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:18145


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: rotator cuff syndrome


subject: UMLS:C4086546

object_name: Rotator cuff tear


subject: CHEBI:67272

subject_name: Perifosine

object_name: Childhood Breast Carcinoma


subject: CHEBI:67272

object_name: breast carcinoma


subject: CHEBI:67272

object_name: breast cancer


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: chronic obstructive pulmonary disease


subject: CHEBI:4031

subject_name: Cyclosporine


subject: UMLS:C0694951

subject_name: INJECTION, AMPHOTERICIN B, 50 MG ADMINISTERED

object_name: Invasive pulmonary aspergillosis


subject: CHEBI:2682

subject_name: Amphotericin B


subject: CHEBI:94559

subject_name: Levocetirizine

object_name: Hay fever


subject: GTOPDB:5070

subject_name: LIGHT

object_name: circadian rhythm sleep disorder, delayed sleep phase type


subject: CHEBI:30212

subject_name: photon


subject: PR:000002222

subject_name: tumor necrosis factor ligand superfamily member 14


subject: CHEBI:36791

subject_name: Escitalopram


subject: CHEBI:3723

subject_name: Citalopram


subject: UniProtKB:P04276

subject_name: VTDB_RAT Vitamin D-binding protein (sprot)

object_name: type 2 diabetes mellitus


subject: UNII:8GZG754X6M

subject_name: Gemtuzumab

object_name: acute myeloid leukemia


subject: UNII:8GZG754X6M

object_name: Myelodysplasia


subject: UMLS:C0677800

subject_name: CMA 676


subject: UMLS:C0677800


subject: CHEBI:50692

subject_name: Mifepristone

object_name: Medical abortion (finding)


subject: CHEBI:63610

subject_name: Misoprostol


subject: UMLS:C0682993

subject_name: carbamazepin (benzodiazepine)

object_name: Drug Resistant Epilepsy


subject: CHEBI:3387

subject_name: Carbamazepine


subject: CHEBI:8107

subject_name: Phenytoin


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:39867

subject_name: Valproic acid


subject: PUBCHEM.COMPOUND:137319706

subject_name: Orforglipron


subject: UNII:7ZW40D021M

subject_name: ORFORGLIPRON


subject: CHEBI:59265

subject_name: palmitelaidic acid

object_name: ulcerative colitis


subject: CHEBI:59265

object_name: inflammatory bowel disease 1


subject: CHEBI:59265

object_name: inflammatory bowel disease


subject: CHEBI:28716

subject_name: Palmitoleic Acid


subject: CHEBI:28716


subject: CHEBI:28716


subject: HMDB:HMDB0253501

subject_name: Insulin degludec

object_name: type 1 diabetes mellitus 1


subject: HMDB:HMDB0253501

object_name: type 1 diabetes mellitus


subject: UMLS:C3489797

object_name: cystic fibrosis


subject: UMLS:C5392674

object_name: schizophrenia


subject: CHEBI:73611

subject_name: Met-Gly

object_name: acute respiratory distress syndrome


subject: CHEBI:73611

object_name: adult acute respiratory distress syndrome


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: PR:000004501

subject_name: attractin


subject: PR:000004501


subject: UMLS:C0487173

subject_name: Mg antigen


subject: UMLS:C0487173


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: rectal carcinoma


subject: UNII:6A901E312A

object_name: rectal cancer


subject: UNII:6A901E312A

object_name: Childhood Rectal Carcinoma


subject: CHEBI:28838

subject_name: Lutein

object_name: age-related macular degeneration


subject: CHEBI:27547

subject_name: Zeaxanthin


subject: UNII:DLG4EML025

subject_name: Secukinumab

object_name: ankylosing spondylitis


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: gastric neoplasm


subject: PUBCHEM.COMPOUND:14907381

object_name: colon carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: colon cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: anus neoplasm


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus

object_name: carcinoma of esophagus


subject: CHEBI:190410

object_name: esophageal cancer


subject: CHEBI:190410

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:190410

object_name: neoplasm of esophagus


subject: CHEBI:190410

object_name: exocrine pancreatic carcinoma


subject: CHEBI:190410

object_name: malignant pancreatic neoplasm


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: UMLS:C5907946

subject_name: B. infantis-based Formulation PBCLN-014

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C5907946

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C5907946

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C5907947

subject_name: Human Milk Oligosaccharides-based Formulation PBCLN-010


subject: UMLS:C5907947


subject: UMLS:C5907947


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: pancreatic neoplasm


subject: CHEBI:63607

subject_name: Linezolid

object_name: tuberculosis


subject: UNII:3A71182L8P

subject_name: Sutezolid


subject: CHEBI:135515

subject_name: Bendamustine

object_name: plasma cell myeloma


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: urothelial carcinoma


subject: UNII:KXG2PJ551I

object_name: transitional cell carcinoma


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: metastatic prostate carcinoma


subject: UNII:4EQZ6YO2HI

object_name: Carcinoma breast stage IV


subject: UNII:4EQZ6YO2HI

object_name: Metastatic malignant neoplasm to bone


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: CHEBI:135928

subject_name: Doripenem

object_name: Bacterial Infections and Mycoses


subject: CHEBI:135928

object_name: pancreatitis


subject: CHEBI:135928

object_name: Pancreatitis, CTCAE 5.0


subject: CHEBI:135928

object_name: Pancreatitis, CTCAE 3.0


subject: CHEBI:135928

object_name: cholecystitis


subject: CHEBI:135928

object_name: Cholecystitis, CTCAE 3.0


subject: CHEBI:135928

object_name: Cholecystitis, CTCAE 5.0


subject: CHEBI:135928

object_name: appendicitis


subject: CHEBI:135928

object_name: Appendicitis, CTCAE


subject: CHEBI:135928

object_name: peritonitis


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: Helicobacter pylori infection


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: PUBCHEM.COMPOUND:129130827

subject_name: Bictegravir

object_name: HIV infection


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: Recurrence


subject: PUBCHEM.COMPOUND:155543961

object_name: Recurrent Malignant Neoplasm


subject: PUBCHEM.COMPOUND:155543961

object_name: Recurrent disease


subject: PUBCHEM.COMPOUND:155543961

object_name: Recurrent tumor


subject: PUBCHEM.COMPOUND:155543961

object_name: atrial fibrillation


subject: PUBCHEM.COMPOUND:155543961

object_name: Atrial Fibrillation by ECG Finding


subject: PUBCHEM.COMPOUND:155543961

object_name: Atrial Fibrillation, CTCAE


subject: PUBCHEM.COMPOUND:155543961

object_name: Overweight and obesity


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: bone Paget disease


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:48390

subject_name: Cinacalcet

object_name: secondary hyperparathyroidism of renal origin


subject: CHEBI:125427


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:6931

subject_name: Midazolam

object_name: dental phobia


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:9130

subject_name: Sevoflurane


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: uveitis


subject: UNII:FYS6T7F842

object_name: Uveitis, CTCAE


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: UMLS:C5417780

subject_name: KRT 232

object_name: myelofibrosis


subject: CHEBI:6121

object_name: strabismus


subject: CHEBI:6121

object_name: strabismus on exam (physical finding)


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:9561

subject_name: Thiopental


subject: CHEBI:9561


subject: CHEBI:102166


subject: CHEBI:102166


subject: CHEBI:17026

subject_name: Progesterone

object_name: Menopause related conditions


subject: UMLS:C1452745

object_name: chronic hepatitis C virus infection


subject: CHEBI:30879

subject_name: alcohol

object_name: impotence


subject: CHEBI:30879

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:30879

object_name: Erectile dysfunction


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:16236


subject: CHEBI:16236


subject: CHEBI:16908

subject_name: NADH

object_name: Post-COVID-19 syndrome


subject: CHEBI:16908

object_name: long COVID-19


subject: CHEBI:16908


subject: CHEBI:16908

object_name: Chronic post-COVID-19 syndrome


subject: CHEBI:15846

subject_name: NAD(+)


subject: CHEBI:15846


subject: CHEBI:15846


subject: CHEBI:15846


subject: CHEBI:13389

subject_name: Nadide


subject: CHEBI:13389


subject: CHEBI:13389


subject: CHEBI:13389


subject: CHEBI:7465

subject_name: Naltrexone


subject: CHEBI:7465


subject: CHEBI:7465


subject: CHEBI:7465


subject: CHEBI:36796

subject_name: duloxetine

object_name: chronic pain (diagnosis)


subject: CHEBI:36796

object_name: Chronic pain


subject: CHEBI:36796

object_name: fibromyalgia


subject: CHEBI:73024

subject_name: O-acetylcarnitine

object_name: carpal tunnel syndrome 1


subject: CHEBI:73024

object_name: carpal tunnel syndrome


subject: CHEBI:73024

object_name: nerve compression syndrome


subject: CHEBI:73024

object_name: hereditary neuropathy with liability to pressure palsies


subject: CHEBI:57589

subject_name: Acetylcarnitine


subject: CHEBI:57589


subject: CHEBI:57589


subject: CHEBI:57589


subject: CHEBI:8378

subject_name: Prednisolone

object_name: drug-induced liver injury


subject: UMLS:C3642443

object_name: squamous cell carcinoma


subject: UMLS:C3642443

object_name: lung adenocarcinoma


subject: PUBCHEM.COMPOUND:4695

subject_name: Isosulfan blue

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:4695

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:4695

object_name: breast cancer


subject: UNII:39N9K8S2A4

subject_name: isosulfan blue


subject: UNII:39N9K8S2A4


subject: UNII:39N9K8S2A4


subject: CHEBI:38940

subject_name: Sunitinib

object_name: malignant soft tissue neoplasm


subject: CHEBI:38940

object_name: sarcoma


subject: CHEBI:38940

object_name: fibromatosis


subject: CHEBI:38940

object_name: desmoid tumor


subject: CHEBI:38940

object_name: Desmoid tumor


subject: CHEBI:38940

object_name: endometrial cancer


subject: CHEBI:38940

object_name: uterine corpus cancer


subject: CHEBI:38940

object_name: endometrial carcinoma


subject: CHEBI:38940

object_name: Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone


subject: CHEBI:38940

object_name: small intestine cancer


subject: CHEBI:38940

object_name: small intestine carcinoma


subject: CHEBI:38940

object_name: ovarian cancer


subject: CHEBI:38940

object_name: ovarian neoplasm


subject: CHEBI:38940

object_name: ovarian carcinoma


subject: CHEBI:60654

subject_name: valproate

object_name: bipolar disorder


subject: CHEBI:60654

object_name: cocaine dependence


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:168243


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: PUBCHEM.COMPOUND:71300755

subject_name: Serelaxin

object_name: heart failure


subject: UNII:W0122B976Y

subject_name: SERELAXIN


subject: CHEBI:8093

subject_name: Phenylephrine

object_name: mitral valve insufficiency


subject: CHEBI:8874

subject_name: Rivastigmine

object_name: complete trisomy 21


subject: CHEBI:8874

object_name: Down syndrome


subject: CHEBI:61080

subject_name: Romidepsin

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:61080

object_name: peripheral T-cell lymphoma, not otherwise specified


subject: CHEBI:61080

object_name: primary cutaneous T-cell non-Hodgkin lymphoma